VNTR2/VNTR3 genotype in the FCGRT gene is associated with reduced effectiveness of intravenous immunoglobulin in patients with myasthenia gravis

BACKGROUND: Intravenous immunoglobulin (IVIG) has been commonly used to treat myasthenia gravis exacerbation, but is still ineffective in nearly 30% of patients. A variable number of tandem repeat (VNTR) polymorphism in the FCGRT gene has been found to reduce the efficiency of IgG biologics. However...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Udgivet i:	Ther Adv Neurol Disord
Main Authors:	Su, Shengyao, Liu, Qing, Zhang, Xueping, Wen, Xinmei, Lei, Lin, Shen, Faxiu, Fan, Zhirong, Duo, Jianying, Lu, Yan, Di, Li, Wang, Min, Chen, Hai, Zhu, Wenjia, Xu, Min, Wang, Suobin, Da, Yuwei
Format:	Artigo
Sprog:	Inglês
Udgivet:	SAGE Publications 2021
Fag:	Original Research
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC7844454/ https://ncbi.nlm.nih.gov/pubmed/33552238 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286420986747
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

VNTR2/VNTR3 genotype in the FCGRT gene is associated with reduced effectiveness of intravenous immunoglobulin in patients with myasthenia gravis

Lignende værker